Psoriatic arthritis impact and activity study
Part of Bones, joints & muscles, Skin clinical trials.
This study looks at how psoriatic arthritis affects your daily life and how that relates to the severity of your condition. It aims to better understand the disease to improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with psoriatic arthritis by a doctor using specific criteria.
- You are 18 years old or older.
- You are willing to take part in the study and sign a consent form.
- You do not have another autoimmune disease (like lupus or rheumatoid arthritis).
- You do not have advanced cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses power Doppler ultrasound to classify and measure how active your psoriatic arthritis is. It may help doctors better understand and treat your condition.
This study looks at how well advanced treatments work for people with psoriatic arthritis, and whether results differ for sex and gender. You may be eligible if your psoriatic arthritis is active and you are planning to start an advanced treatment for symptoms in the joints and surrounding areas.
This study looks at people with early arthritis related to rheumatoid arthritis, psoriatic arthritis, or psoriasis. Researchers want to understand how these early conditions behave and may help guide better treatment decisions.
This study tests a combined program of intense aerobic and strength training to see if it improves disease activity and function in people with psoriatic arthritis. You would either join the training group or continue your usual care, and researchers will track your progress over 3 months.
This observational study is looking at adults with skin psoriasis and collecting real-world information about their condition and experiences. It may help researchers better understand psoriasis and how it affects people, without giving a new treatment.
This study looks at how inflammatory “cytokines” are expressed in people with psoriasis—both those with joint involvement and those without. It may help researchers understand what drives joint disease and guide better future monitoring or treatments.
Hear when a new Psoriatic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.